{"id":"https://openalex.org/W1992009754","doi":"https://doi.org/10.5665/sleep.3208","title":"Efficacy of Vestipitant, A Neurokinin-1 Receptor Antagonist, in Primary Insomnia","display_name":"Efficacy of Vestipitant, A Neurokinin-1 Receptor Antagonist, in Primary Insomnia","publication_year":2013,"publication_date":"2013-11-26","ids":{"openalex":"https://openalex.org/W1992009754","doi":"https://doi.org/10.5665/sleep.3208","mag":"1992009754","pmid":"https://pubmed.ncbi.nlm.nih.gov/24293756","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3825431"},"language":"en","primary_location":{"id":"doi:10.5665/sleep.3208","doi":"https://doi.org/10.5665/sleep.3208","is_oa":true,"landing_page_url":"https://doi.org/10.5665/sleep.3208","pdf_url":"https://academic.oup.com/sleep/article-pdf/36/12/1823/26661825/aasm.36.12.1823.pdf","source":{"id":"https://openalex.org/S42921845","display_name":"SLEEP","issn_l":"0161-8105","issn":["0161-8105","1550-9109"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sleep","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/sleep/article-pdf/36/12/1823/26661825/aasm.36.12.1823.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006715899","display_name":"Emiliangelo Ratti","orcid":"https://orcid.org/0000-0002-7352-4695","observed_orcids":["https://orcid.org/0000-0002-7352-4695"]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Emiliangelo Ratti","raw_affiliation_strings":["GlaxoSmithKline Neuroscience Centre of Excellence for Drug Discovery, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Neuroscience Centre of Excellence for Drug Discovery, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075569712","display_name":"David James Carpenter","orcid":"https://orcid.org/0000-0002-9261-7168","observed_orcids":["https://orcid.org/0000-0002-9261-7168"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David J. Carpenter","raw_affiliation_strings":["GlaxoSmithKline Discovery Medicine, Neurosciences Centre for Excellence in Drug Discovery, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Discovery Medicine, Neurosciences Centre for Excellence in Drug Discovery, Philadelphia, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079783310","display_name":"Stefano Zamuner","orcid":"https://orcid.org/0000-0003-1071-1829","observed_orcids":["https://orcid.org/0000-0003-1071-1829"]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Stefano Zamuner","raw_affiliation_strings":["GlaxoSmithKline Neuroscience Centre of Excellence for Drug Discovery, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Neuroscience Centre of Excellence for Drug Discovery, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sofia Fernandes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sofia Fernandes","raw_affiliation_strings":["GlaxoSmithKline Neuroscience Centre of Excellence for Drug Discovery, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Neuroscience Centre of Excellence for Drug Discovery, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008773192","display_name":"Lisa Squassante","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lisa Squassante","raw_affiliation_strings":["GlaxoSmithKline Neuroscience Centre of Excellence for Drug Discovery, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Neuroscience Centre of Excellence for Drug Discovery, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073883544","display_name":"Heidi Danker\u2010Hopfe","orcid":"https://orcid.org/0000-0001-7001-1715","observed_orcids":["https://orcid.org/0000-0001-7001-1715"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Heidi Danker-Hopfe","raw_affiliation_strings":["Competence Centre of Sleep Research and Sleep Medicine, Charit\u00e9 - University Medicine Berlin, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Competence Centre of Sleep Research and Sleep Medicine, Charit\u00e9 - University Medicine Berlin, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111594123","display_name":"Graeme E. Archer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Graeme Archer","raw_affiliation_strings":["GlaxoSmithKline (GSK), Neurosciences Discovery Biometrics, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline (GSK), Neurosciences Discovery Biometrics, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113732040","display_name":"Jonathan Robertson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jonathan Robertson","raw_affiliation_strings":["GlaxoSmithKline (GSK), Neurosciences Discovery Biometrics, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline (GSK), Neurosciences Discovery Biometrics, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103079586","display_name":"Robert Alexander","orcid":"https://orcid.org/0000-0002-6889-2952","observed_orcids":["https://orcid.org/0000-0002-6889-2952"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Alexander","raw_affiliation_strings":["GlaxoSmithKline Discovery Medicine, Neurosciences Centre for Excellence in Drug Discovery, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Discovery Medicine, Neurosciences Centre for Excellence in Drug Discovery, Philadelphia, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054988763","display_name":"David G. Trist","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"David G. Trist","raw_affiliation_strings":["GlaxoSmithKline Neuroscience Centre of Excellence for Drug Discovery, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Neuroscience Centre of Excellence for Drug Discovery, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028670732","display_name":"Emilio Merlo\u2010Pich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Emilio Merlo-Pich","raw_affiliation_strings":["GlaxoSmithKline Neuroscience Centre of Excellence for Drug Discovery, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Neuroscience Centre of Excellence for Drug Discovery, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5075569712"],"corresponding_institution_ids":["https://openalex.org/I4210114143"],"apc_list":{"value":4388,"currency":"USD","value_usd":4388},"apc_paid":null,"fwci":2.2519,"has_fulltext":true,"cited_by_count":51,"citation_normalized_percentile":{"value":0.87994021,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"36","issue":"12","first_page":"1823","last_page":"1830"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10985","display_name":"Sleep and Wakefulness Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10342","display_name":"Circadian rhythm and melatonin","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nk1-receptor-antagonists","display_name":"NK1 receptor antagonists","score":0.9769999980926514},{"id":"https://openalex.org/keywords/primary-insomnia","display_name":"primary insomnia","score":0.9330000281333923},{"id":"https://openalex.org/keywords/hypnotic-efficacy","display_name":"hypnotic efficacy","score":0.6830000281333923},{"id":"https://openalex.org/keywords/wake-after-sleep-onset","display_name":"wake after sleep onset","score":0.9390000104904175},{"id":"https://openalex.org/keywords/sleep-maintenance","display_name":"sleep maintenance","score":0.7910000085830688},{"id":"https://openalex.org/keywords/sleep-onset-latency","display_name":"sleep latency","score":0.722000002861023},{"id":"https://openalex.org/keywords/total-sleep-time","display_name":"total sleep time","score":0.9959999918937683},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7179999947547913},{"id":"https://openalex.org/keywords/headache","display_name":"headache","score":0.7549999952316284},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.7900000214576721}],"concepts":[{"id":"https://openalex.org/C2910380747","wikidata":"https://www.wikidata.org/wiki/Q1869874","display_name":"Primary Insomnia","level":4,"score":0.7999117970466614},{"id":"https://openalex.org/C2781210498","wikidata":"https://www.wikidata.org/wiki/Q1869874","display_name":"Insomnia","level":2,"score":0.7302797436714172},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.7101232409477234},{"id":"https://openalex.org/C137130169","wikidata":"https://www.wikidata.org/wiki/Q15316325","display_name":"Tachykinin receptor 1","level":5,"score":0.6167886257171631},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49533048272132874},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4731634259223938},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.463519424200058},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4090232253074646},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.34968066215515137},{"id":"https://openalex.org/C1513209611","wikidata":"https://www.wikidata.org/wiki/Q177190","display_name":"Sleep disorder","level":3,"score":0.3094574213027954},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26797616481781006},{"id":"https://openalex.org/C118303440","wikidata":"https://www.wikidata.org/wiki/Q419968","display_name":"Neuropeptide","level":3,"score":0.14333319664001465},{"id":"https://openalex.org/C2776533618","wikidata":"https://www.wikidata.org/wiki/Q411041","display_name":"Substance P","level":4,"score":0.07198849320411682}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005464","descriptor_name":"Fluorobenzenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007319","descriptor_name":"Sleep Initiation and Maintenance Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017286","descriptor_name":"Polysomnography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064729","descriptor_name":"Neurokinin-1 Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.5665/sleep.3208","doi":"https://doi.org/10.5665/sleep.3208","is_oa":true,"landing_page_url":"https://doi.org/10.5665/sleep.3208","pdf_url":"https://academic.oup.com/sleep/article-pdf/36/12/1823/26661825/aasm.36.12.1823.pdf","source":{"id":"https://openalex.org/S42921845","display_name":"SLEEP","issn_l":"0161-8105","issn":["0161-8105","1550-9109"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sleep","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3825431","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3825431","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sleep","raw_type":"Text"},{"id":"pmid:24293756","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24293756","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sleep","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.5665/sleep.3208","doi":"https://doi.org/10.5665/sleep.3208","is_oa":true,"landing_page_url":"https://doi.org/10.5665/sleep.3208","pdf_url":"https://academic.oup.com/sleep/article-pdf/36/12/1823/26661825/aasm.36.12.1823.pdf","source":{"id":"https://openalex.org/S42921845","display_name":"SLEEP","issn_l":"0161-8105","issn":["0161-8105","1550-9109"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sleep","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1992009754.pdf","grobid_xml":"https://content.openalex.org/works/W1992009754.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W39816332","https://openalex.org/W84020626","https://openalex.org/W136133435","https://openalex.org/W201862730","https://openalex.org/W1271912162","https://openalex.org/W1545689369","https://openalex.org/W1585819624","https://openalex.org/W1603085026","https://openalex.org/W1798864434","https://openalex.org/W1971277989","https://openalex.org/W1972437651","https://openalex.org/W1991934169","https://openalex.org/W1999380529","https://openalex.org/W2003665363","https://openalex.org/W2008308163","https://openalex.org/W2009845727","https://openalex.org/W2016021688","https://openalex.org/W2024799385","https://openalex.org/W2029126668","https://openalex.org/W2036316219","https://openalex.org/W2038637825","https://openalex.org/W2045030807","https://openalex.org/W2051912287","https://openalex.org/W2053311281","https://openalex.org/W2058713081","https://openalex.org/W2062350167","https://openalex.org/W2069849218","https://openalex.org/W2073460305","https://openalex.org/W2073690654","https://openalex.org/W2075363447","https://openalex.org/W2079328435","https://openalex.org/W2082850379","https://openalex.org/W2099661804","https://openalex.org/W2104773693","https://openalex.org/W2107482353","https://openalex.org/W2110207143","https://openalex.org/W2111180320","https://openalex.org/W2117213785","https://openalex.org/W2130892279","https://openalex.org/W2135997508","https://openalex.org/W2140799285","https://openalex.org/W2169477960","https://openalex.org/W2525537354","https://openalex.org/W3022302886","https://openalex.org/W4231896431","https://openalex.org/W4255396331","https://openalex.org/W6651184769"],"related_works":["https://openalex.org/W2481418614","https://openalex.org/W3029491519","https://openalex.org/W2936638370","https://openalex.org/W2025250287","https://openalex.org/W2071080249","https://openalex.org/W2118073129","https://openalex.org/W1558643444","https://openalex.org/W4414367222","https://openalex.org/W2082143875","https://openalex.org/W2048722880"],"abstract_inverted_index":{"STUDY":[0],"OBJECTIVES:":[1],"Investigate":[2],"the":[3,97,172],"hypnotic":[4],"effects":[5,149,201],"of":[6,9,96,150,163,177],"repeated":[7,100,214],"doses":[8],"neurokinin-1":[10],"receptor":[11],"antagonist,":[12],"vestipitant,":[13],"in":[14,28,161,189],"primary":[15,36,192],"insomnia.":[16,37],"DESIGN:":[17],"Randomized,":[18],"double-blind,":[19],"placebo-controlled":[20],"28-day":[21],"parallel-group":[22],"study.":[23],"SETTING:":[24],"Eleven":[25],"sleep":[26,63,105,124,187,205,209],"centers":[27],"Germany.":[29],"PATIENTS:":[30],"One":[31],"hundred":[32],"sixty-one":[33],"patients":[34,165,179,190],"with":[35,108,128,191,194],"INTERVENTIONS:":[38],"Patients":[39],"received":[40],"vestipitant":[41,74,109,129,151,164,178],"(15":[42],"mg)":[43],"or":[44],"placebo":[45,76],"for":[46,168,182],"28":[47],"days;":[48],"2-night":[49],"polysomnographic":[50],"assessment":[51],"occurred":[52,160],"on":[53,68,110,120,202],"nights":[54,69,111,121,135],"1/2":[55,70,112],"and":[56,71,86,207],"27/28.":[57,122],"MEASUREMENTS":[58],"AND":[59],"RESULTS:":[60],"Wake":[61],"after":[62,204],"onset":[64,206],"(WASO)":[65],"was":[66,106,171],"improved":[67,127,186],"27/28":[72],"(ratio,":[73],"versus":[75,116,140,155,166,180],"[95%":[77],"confidence":[78],"interval]:":[79],"0.76":[80],"[0.65,":[81,88],"0.90],":[82],"P":[83,90,132,137],"=":[84,91,114,138],"0.001":[85],"0.79":[87],"0.96],":[89],"0.02,":[92],"respectively),":[93],"demonstrating":[94],"maintenance":[95,188],"effect":[98],"following":[99,213],"dosing.":[101,215],"Latency":[102],"to":[103],"persistent":[104],"shorter":[107],"(P":[113,152],"0.0006":[115],"placebo),":[117],"but":[118],"not":[119],"Total":[123],"time":[125,210],"(TST)":[126],"(nights":[130],"1/2:":[131],"<":[133],"0.0001,":[134],"27/28:":[136],"0.02":[139],"placebo).":[141,156,183],"Next-day":[142],"cognitive":[143,198],"function":[144],"tests":[145],"demonstrated":[146],"no":[147,195],"residual":[148],">":[153],"0.05":[154],"Adverse":[157],"events":[158],"(AEs)":[159],"25%":[162],"22%":[167],"placebo.":[169],"Headache":[170],"most":[173],"common":[174],"AE":[175],"(8%":[176],"9%":[181],"CONCLUSIONS:":[184],"Vestipitant":[185],"insomnia,":[193],"associated":[196],"next-day":[197],"impairment.":[199],"The":[200],"wake":[203],"total":[208],"were":[211],"maintained":[212]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}